Chefarzt der Neurologie informiert über Gehirn und Nerven im Rahmen der COVID-19 Pandemie. NeuroCovid
Parkinson & Corona: Vitamin D, Immunsystem, Telemedizin
#coronaneuro #anfälle #parkinson #neurocovid #vitamind
#corona #neurologie #neurology #gehirn #nervensystem #covid19 #sarscov2 #sars #chefarzt #wissenschaft #medizin #information #neurology #brain #pandemie #info #duesseldorf #stayinformed #stayhealthy #wirbleibenzuhause @hospitalkempen @hhu_de @uniklinikdus #kempen
Referenzen:
Management of Advanced Therapies in Parkinson’s Disease Patients in times of Humanitarian crisis: the COVID ‐19 experience. Fasano A, Antonini A, Katzenschlager R, Krack P, Odin P, Evans AH, Foltynie T, Volkmann J, Merello M. Mov Disord Clin Pract. 2020 Apr 20
Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy Tommaso Schirinzi et al.Neurological Sciences.
Mental health, physical activity and quality of life in Parkinson’s disease during COVID-19 pandemic. Ali Shalash et al. Mov Disord, in press
The Impact of the COVID-19 Pandemic on Parkinson’s Disease: Hidden Sorrows and Emerging Opportunities. Helmich RC, Bloem BR. J Parkinsons Dis. 2020; 10(2) 351-354. DOI: 10.3233/JPD-202038, PMID: 32250324
COVID-19 in Parkinson’s Disease Patients Living in Lombardy, Italy. Fasano et al. Mov Disord, in press
Rejdak K, Grieb P. Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment. Mult Scler Relat Disord 2020 Apr 30; 42: 102163 . doi: 10.1016/j.msard.2020.102163. [Epub ahead of print]; (20)30239-X/fulltext
Tele-health in neurology: an indispensable tool in the management of the SARS-CoV-2 epidemic. Ruggero Capra & Flavia Mattioli. Journal of Neurology (2020) Published: 12 May 2020
The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders. Bastiaan R. Bloem, E. Ray Dorsey, Michael S. Okun. JAMA Neurol. Published online April 24, 2020. doi:10.1001/jamaneurol.2020.1452.
Cerebrospinal Fluid Antibodies to Coronavirus in Patients With Parkinson’s Disease. E Fazzini 1, J Fleming, S Fahn. Mov Disord 1992;7(2):153-8. doi: 10.1002/mds.870070210.
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease. Cecilia S. Lindestam Arlehamn et al.NATURE COMMUNICATIONS | (2020)11:1875 |
A Post-COVID-19 Parkinsonism in the Future?. Aliaksandr V. Boika,Mov Disord DOI: 10.1002/mds.28117
